Trial intelligence / Profile preview

Regulation of the stress-axis by vitamin D3 in female relapsing-remitting multiple sclerosis

2014-000728-97Phase 2Terminated

Sponsor
Academic MS Center Limburg
Start
May 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in multiple sclerosis (MS) comparing Vitamin D3 (Vigantol Oil) with Placebo (2 arms). Primary endpoint: Area under the curve of the cortisol day curve. Started May 2014; status: terminated.

02

Drugs

cholecalciferol
03

Conditions

multiple sclerosis (MS)

Beyond the preview

Go deeper on 2014-000728-97.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2014-000728-97.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call